TherapeuticsMD Stock (NASDAQ: TXMD) stock price, news, charts, stock research, profile.
Open | $2.020 |
Close | - |
Volume / Avg. | 694.000 / 22.147K |
Day Range | 2.020 - 2.020 |
52 Wk Range | 1.950 - 4.725 |
Market Cap | $23.296M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 23 |
Short Interest | 0.47% |
Days to Cover | 2.27 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of TherapeuticsMD (NASDAQ: TXMD) through any online brokerage.
Other companies in TherapeuticsMD’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Jaguar Health (NASDAQ:JAGX).
The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Cantor Fitzgerald on Thursday, August 17, 2023. The analyst firm set a price target for 5.00 expecting TXMD to rise to within 12 months (a possible 129.36% upside). 1 analyst firms have reported ratings in the last year.
The stock price for TherapeuticsMD (NASDAQ: TXMD) is $2.18 last updated April 10, 2024 at 8:53 AM EDT.
There are no upcoming dividends for TherapeuticsMD.
TherapeuticsMD’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for TherapeuticsMD.
TherapeuticsMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.